Buh bye
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
3 days
So, looks like my "hunch" may turn out to be right. Guess we'll find out soon enough.
"many are willing to give up the ghost for peanuts, simply because of a temporary share price. Never should have invested in clinical biotech in the first place."
And this is the summation of it all.
Thank you.
I don't understand why folks are expecting imminent deals and such? All of that thinking was mostly conceived because of people's opinions and speculation from this board (including me). The only thing we know is that it appears the POR is still in place, with a refocus to bring shareholder value. Additionally, we know they are working very hard to meet EMA submission goals.
Beyond that, it's all speculation. I speculate that Monday may bring some encouraging forward guidance from Mr. Lombardo. However, I'm only speculating. Getting back to what I believe:
1. The science works
2. Unless there is concrete proof to the contrary, EMA submission is in the queue for Q4
3. From the data we have, it's probable that AA EA is achieved in 2018.
So, if the above transpires and/or is true, one can speculate that the pps will follow, and in a very dramatic fashion.
Beyond that it's a bunch of folks posting emotional responses to a lagging pps, coupled with a bunch folks posting outright FUD, coupled with a bunch of folks posting random opinions.
After all, this is just a message board, not an Advaxis fact board.
Today was especially juicy though. It's like the world is going to end on September 23rd!
I never stated "there will be a big announcement". I just stated I have a hunch something may show up.
The post below proves you are a liar
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134749041
Regardless of what is communicated Monday, as long as it's not vanilla or concerning news, the next big items are licensing deal and/or EMA submission.
I've always maintained that 2018 is the year that Advaxis should really take off. It would be nice to have a good base pps to launch from - say around $20 or so. Hopefully, the pps can climb to the original highs or thereabouts before EU AA. From there, the pps will skyrocket.
As early as Monday...
When are you expecting to get to fair market value again?
You don't want lawsuits on the portfolio when you're for sale...
Doh, did I just say that?
Knowing and predicting are two very different things. Hope you understand that. It's plainly obvious that Advaxis has milestones it must reach near-term and long-term. So, connecting the dots along the way takes a little luck and a little insight.
Ignore at your own risk.
Keep it simple Steve. Keep it simple.
Ya know, methinks something may show-up in Mr. Lombardo's talk Monday - just a hunch
Sell the company now, Just sell the company, Dilution is, Pink sheets are, No approvals. No strategy. No CEO, The world economy is on the brink, Get rid of the BOD, Get rid of Noelle, Layoff 20% and cut salaries by 10%, $7.00 $6.00 $5.00 $4.00 $3.00 etc, 'Hanging by the thread' is what the state of ADXS is as of now, The stock price now puts them in survival mode, No doggie vaccine, no india, no EU filing, no licensing deals, no nothing
*************** Foolish Unrelenting Dogma ******************
You sound emotional and concerned. I'm not. Always have a plan. Remember to always have a plan, instead of allowing the daily, random, fluctuation of a volatile biotech equity influence your daily well-being.
So many on this board don't get it.
If I don't buy or sell, what value translates into my day-to-day? When you figure out the answer, you'll understand.
You do realize that the "current" pps means shite, right?
I agree.
"My position is/was that I feel/felt the company can achieve a price higher than when I bought in, eventually, and it's being held back by whomever is masterminding this nonsense."
Exactly my point.
Insert company name <company name>
"My position is/was that I feel/felt <company name> can achieve a price higher than when I bought in, eventually, and it's being held back by whomever is masterminding this nonsense."
Some things never change...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=134662704
Material news people. Material news.
I don't understand your convictions or position with respect to Advaxis. It's so generic, it can apply to any equity.
Dilution is not remotely close to being a palatable option at these prices, especially considering the last series of events under DOC post the Amgen deal.
I don't think they're that smart. They're gonna get caught and when they do, it's going to be very, very ugly for them.
Today's action proves what I said last week. The pps, today, means shite, and will continue to mean shite until there is a material event. As I've stated in the past, I do believe the following sequence of events will happen before 2019, or thereabouts.
Announcement of either a licensing deal, EU partership or both
-this may or may not happen before EMA submission
then...
EMA submission->AA EU approval->AA FDA approval
Buyout window (options)
1. Post EMA submission, prior to AA EU or AA FDA
2. Post AA EU
3. Post AA EU and AA FDA
I suspect a buyout could occur post EMA submission, prior to AA EU. I also believe the price in this scenario would be around 4.2 billion. However, if Advaxis can hold on and grow and extend beyond FDA approval, the buyout price would exceed Kite's buyout price. No matter how it's spun, I don't think Advaxis can avoid a buyout before 2020.
So, who gives a rip about today's share price. I don't. I know the fundamentals haven't changed and the science is solid.
The pps will come accordingly in due time.
This is fair and honest insight.
If you are a "true believer" as you say, then filing in Q4 or Q1 of 2018 is irrelevant, except for the pps at that time. So if your timeframe is months, in terms of very major appreciation, you're probably going to be disappointed.
I think licensing has a better chance of landing first, i.e. before EU partnership. Regardless, if Advaxis announces either the pps will never look back, since compounding events will just build on each other. Hopefully, they move it back to the 7's before either is announced. From there it's easy double, possibly triple, but this time no major regression.
It would be an ideal scenario to see the following: Licensing followed by EU partnership followed by EMA submission
The pps would probably be at an all-time high if the above happens. Then throw in AA EU and/or FDA approval and you have your triple-digits or near triple-digits. Add the buyout, and that's all she wrote. All of this can happen before 2020. Hopefully some material news transpires before 2018 or the pps will continue to lag.
Rumor has it that the top three rumors going are, in priority order,:
1. Buy out imminent
2. EU partnership imminent
3. Licensing deal imminent
The little birdie must be busy these days.
Incredible, amazing post! WHERE did you get this data?
WOW!!!!!
I need to celebrate and eat a twinkie.
Yuppers
A post to mark. Remember THIS past week and take notice of the all of the commentary on this board when things "change" again.
I'm with you in terms of "paper" loss, but I had no intentions of selling this week or next week or next month or next year. So today's price is essentially irrelevant to me. What I do care about are the fundamentals. They have NOT changed. If anything they have become more crisp, more focused.
If EMA and/or EU approval fails, then we can cut the losses. Until then, the pps is smoke and mirrors, whether it's sitting at $5 or $25.
I have no idea what the stock will do next week. Your memory is very short. You know the stock climbed 102% in 12 days last July, correct?
There is no way to predict what will happen in the absence of material events. In all seriousness, you should take a break.
All of your assertions are because of the last 3 days. If the stock moves to $9 next week, will you say the same things? You should, but you won't. And the reason you won't is because you are emotionally attached to the investment, which is basically an emotional death sentence.
If I was you, honestly, I would turn off his board and my PC for a month.
"This is a pretty big setback and is probably the main impetus for the sharp decline in the share price since the 9/11/17 PR, IMO."
EXACTLY - in your opinion. Convenient.
I'll state the very obvious since everybody is such a fuss over the recent set of events.
1. In case you don't know, you're invested in a biotech equity that has not product or no approval - YET. This means:
A. Volatility is king. End of story. So, remove your emotions.
B. Pre "material news", stock swings, either way are bullshite facades
C. When you hear claims of reasons of events, just opinions, not facts
So, summarizing:
1. Expect the unexpected until "material" event(s). This means the stock could just as easily go to $9+ in two days, for no reason at all.
2. If you need to sell now, I sympathize - that would suck.
3. Until EMA submission and EU approval, continue to expect volatility.
My point is that we can't get stuck on the daily changes until Advaxis moves into more "mature" fundamentals.
Until then, volatility is king.
They shorted it 35% ($7.45 to $4.82) in TWO days starting on 9/11/2017
They raised it 102% ($8.06 to $16.30) in TEN days starting on 7/27/2016
Sooooooooooooooo,
NOTHING SHOULD SURPRISE ANYBODY ON THE MOVES THIS STOCK CAN MAKE!
By November, with the right material news, it could easily be trading over $30.
If a cat catches a mouse and nobody is around to see it, did the cat actually catch the mouse?